Literature DB >> 30995504

IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation.

Wenjun Ouyang1, Anne O'Garra2.   

Abstract

Cytokines are among the most important effector and messenger molecules in the immune system. They profoundly participate in immune responses during infection and inflammation, protecting against or contributing to diseases such as allergy, autoimmunity, and cancer. Manipulating cytokine pathways, therefore, is one of the most effective strategies to treat various diseases. IL-10 family cytokines exert essential functions to maintain tissue homeostasis during infection and inflammation through restriction of excessive inflammatory responses, upregulation of innate immunity, and promotion of tissue repairing mechanisms. Their important functions in diseases are supported by data from many preclinical models, human genetic studies, and clinical interventions. Despite significant efforts, however, there is still no clinically approved therapy through manipulating IL-10 family cytokines. Here, we summarize the recent progress in understanding the biology of this family of cytokines, suggesting more specific strategies to maneuver these cytokines for the effective treatment of inflammatory diseases and cancers.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30995504     DOI: 10.1016/j.immuni.2019.03.020

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  196 in total

Review 1.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  Decoding the Body Language of Immunity: Tackling the Immune System at the Organism Level.

Authors:  Nicolas Chevrier
Journal:  Curr Opin Syst Biol       Date:  2019-11-06

3.  IL-22 Signaling in the Tumor Microenvironment.

Authors:  Runqiu Jiang; Beicheng Sun
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Synthetic interleukin 22 (IL-22) signaling reveals biological activity of homodimeric IL-10 receptor 2 and functional cross-talk with the IL-6 receptor gp130.

Authors:  Sofie Mossner; Marcus Kuchner; Nastaran Fazel Modares; Birgit Knebel; Hadi Al-Hasani; Doreen M Floss; Jürgen Scheller
Journal:  J Biol Chem       Date:  2020-07-01       Impact factor: 5.157

5.  Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss.

Authors:  Yehfang Hu; Yamila Carpio; Callum Scott; Ayham Alnabulsi; Abdo Alnabulsi; Tingyu Wang; Fuguo Liu; Milena Monte; Tiehui Wang; Christopher J Secombes
Journal:  Dev Comp Immunol       Date:  2019-07-12       Impact factor: 3.636

6.  Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain.

Authors:  Paul A Clark; Raghava N Sriramaneni; Amber M Bates; Won Jong Jin; Justin C Jagodinsky; Reinier Hernandez; Trang Le; Justin J Jeffery; Ian R Marsh; Joseph J Grudzinski; Eduardo Aluicio-Sarduy; Todd E Barnhart; Bryce R Anderson; Ishan Chakravarty; Ian S Arthur; KyungMann Kim; Jonathan W Engle; Bryan P Bednarz; Jamey P Weichert; Zachary S Morris
Journal:  Radiat Res       Date:  2021-06-01       Impact factor: 2.841

Review 7.  Epigenetic and transcriptional mechanisms for the regulation of IL-10.

Authors:  Huiyuan Zhang; Vijay Kuchroo
Journal:  Semin Immunol       Date:  2019-10-30       Impact factor: 11.130

8.  Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model.

Authors:  Gene T Yocum; Julie J Hwang; Maya Mikami; Jennifer Danielsson; Aisha S Kuforiji; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-12-04       Impact factor: 5.464

9.  Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis.

Authors:  Jerry Chien-Chieh Huang; Matthew Schleisman; Dongseok Choi; Claire Mitchell; Lindsey Watson; Mark Asquith; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2019-11-25       Impact factor: 3.070

Review 10.  Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task.

Authors:  Guoying Ni; Lu Zhang; Xiaodan Yang; Hejie Li; Bowei Ma; Shelley Walton; Xiaolian Wu; Jianwei Yuan; Tianfang Wang; Xiaosong Liu
Journal:  Hum Vaccin Immunother       Date:  2020-03-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.